Ted Buchan & Co Cuts Stake in SPDR S&P Biotech ETF $XBI

Ted Buchan & Co cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 97.7% in the 3rd quarter, Holdings Channel.com reports. The fund owned 2,169 shares of the exchange traded fund’s stock after selling 90,585 shares during the period. Ted Buchan & Co’s holdings in SPDR S&P Biotech ETF were worth $217,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Capital A Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF during the 2nd quarter valued at about $26,000. Johnson Financial Group Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $31,000. Twin Peaks Wealth Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $32,000. Davis Capital Management purchased a new position in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $35,000. Finally, Halbert Hargrove Global Advisors LLC bought a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $40,000.

SPDR S&P Biotech ETF Trading Down 0.2%

Shares of XBI opened at $127.37 on Friday. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $132.09. The business’s fifty day simple moving average is $125.25 and its two-hundred day simple moving average is $112.72. The company has a market cap of $8.51 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.